Project Grant CLSS00000071052

This $385,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to advance integrated treatment for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD) in real-world settings. The key objectives are to: Assess the effectiveness of integrated treatment approaches, including first-line medications and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for patients with co-occurring OUD...

This $2,570,500 project grant from the Department of Health and Human Services Health Resources and Services Administration supports the development and operation of an integrated substance use disorder training program. Funded under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732), the award supports a consortium approach to establish a post-graduate training program for nurse practitioners and physician assistants. The program will provide training for these...

The University of Mississippi Medical Center received a $390,596 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The award, titled "SUD Treatment Expansion in Mississippi (STEM)", aims to reduce recidivism, morbidity, and mortality related to substance use disorders (SUDs) and co-occurring mental health disorders,...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop and evaluate a customized version of the "MyTrials" remote biomarker capture system for use in decentralized clinical trials (DCTs) for substance use disorders (SUDs). The key products and services to be delivered include: 1) Refinement of the existing MyTrials prototype to support the...

This federal Project Grant award of $120,348.00, provided by the U.S. Department of Agriculture (USDA) Rural Utilities Service's Distance Learning and Telemedicine (DLT) Loans and Grants program (CFDA 10.855), supports the Southern Tier Health Care System, Inc. (STHCS) in delivering substance use disorder-related educational services to rural communities in New York. The funding will enable STHCS, a non-profit organization, to utilize telecommunications technologies to remotely provide substance...

The Louisiana Department of Health (LDH), through its Office of Behavioral Health (OBH), was awarded a $54,004,380 Project Grant under the Substance Abuse and Mental Health Services Administration's (SAMHSA) Opioid State Targeted Response (Opioid STR) program (CFDA 93.788). The grant, titled "Louisiana State Opioid Response (LASOR) 4.0," aims to enhance statewide prevention, treatment, and recovery support services for individuals with or at risk of opioid use disorder (OUD) and/or...

The Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), has awarded a $800,000 Project Grant to the Denver Health and Hospital Authority (Denver Health) to implement the Judicial Substance Treatment & Recovery (JUST Recovery) program. The 5-year program aims to provide integrated substance use disorder (SUD) treatment, including medications...

The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $700,000 Project Grant under the Congressional Directives program (CFDA 93.493) to Crossroads Community Health Clinic, Inc. (dba Taos Whole Community Health) in Taos, NM. The grant funds an "Integrative Approach to Community-Based Long-Term Recovery" program that aims to enhance long-term recovery for individuals with opioid use disorder in Taos County. The program integrates mind-body medicine, group...

This $400,000 Project Grant award, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, will allow Clackamas County, Oregon to expand substance use disorder (SUD) treatment and recovery support services in its existing adult drug court programs. Specifically, the county will use the funds to improve abstinence from substance use by expanding...

This $400,000 Project Grant award, provided by the Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) under CFDA Program 93.243 (Substance Abuse and Mental Health Services Projects of Regional and National Significance), will fund an expansion and enhancement of the Livingston County Adult Drug Court (ADC) program in Michigan. The key objectives are to: 1) Increase the ADC's capacity by 20 participants to serve a total of 70...